Beta Bionics (BBNX) Total Non-Current Liabilities (2023 - 2026)
Beta Bionics (BBNX) posted Total Non-Current Liabilities of $34.4 million for Q2 2026, up 8.79% sequentially from $31.6 million in Q1 2026, and up 25.85% YoY from $27.3 million in Q2 2025.
Beta Bionics (BBNX) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
Beta Bionics has reported Total Non-Current Liabilities for 4 years, with the latest figure at $34.4 million in Q2 2026.
- Quarterly Total Non-Current Liabilities rose 25.85% year-over-year to $34.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $34.4 million (up 25.85% YoY) and the FY2025 annual result came in at $39.6 million, up 37.77% from the prior year.
- Total Non-Current Liabilities climbed to $34.4 million in Q2 2026 per BBNX's latest filing, from $31.6 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $39.6 million in Q4 2025 and troughed at $23.9 million in Q1 2025.
- A 4-year average of $31.1 million and a median of $30.4 million in 2023 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities slipped 1.3% in 2024, then jumped 37.77% in 2025.
- Over 4 years, Total Non-Current Liabilities stood at $29.1 million in 2023, then retreated by 1.3% to $28.7 million in 2024, then surged by 37.77% to $39.6 million in 2025, then declined by 13.12% to $34.4 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $34.4 million, $31.6 million, and $39.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Beta Bionics | 865.29 Mn | 684.80 Mn | 18.90 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.39 Mn |
| Mar 31, 2026 | 31.61 Mn |
| Dec 31, 2025 | 39.59 Mn |
| Sep 30, 2025 | 34.08 Mn |
| Jun 30, 2025 | 27.33 Mn |
| Mar 31, 2025 | 23.87 Mn |
| Dec 31, 2024 | 28.73 Mn |
| Dec 31, 2023 | 29.11 Mn |